These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1662878)

  • 1. Systemic management of cutaneous bacterial infections.
    Parish LC; Witkowski JA
    Am J Med; 1991 Dec; 91(6A):106S-110S. PubMed ID: 1662878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin.
    Parish LC; Jungkind DL
    Am J Med; 1991 Dec; 91(6A):115S-119S. PubMed ID: 1662880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temafloxacin: an overview.
    Pankey GA
    Am J Med; 1991 Dec; 91(6A):166S-172S. PubMed ID: 1662889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of quinolones in the treatment of infections of the skin and skin structure.
    Gentry LO
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():97-110. PubMed ID: 1787128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of quinolones for the treatment of acute exacerbations of chronic bronchitis.
    Chodosh S
    Am J Med; 1991 Dec; 91(6A):93S-100S. PubMed ID: 1662900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fluoroquinolones as treatment for infections caused by gram-positive bacteria.
    Cruciani M; Bassetti D
    J Antimicrob Chemother; 1994 Mar; 33(3):403-17. PubMed ID: 8040107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolones in the treatment of lower respiratory tract infections.
    Thys JP; Jacobs F; Motte S
    Rev Infect Dis; 1989; 11 Suppl 5():S1212-9. PubMed ID: 2672250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the fluoroquinolone antibiotics.
    Just PM
    Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind randomized study of oral temafloxacin and cefadroxil in patients with mild to moderately severe bacterial skin infections.
    Neldner KH
    Am J Med; 1991 Dec; 91(6A):111S-114S. PubMed ID: 1662879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.
    Paton JH; Reeves DS
    Drugs; 1988 Aug; 36(2):193-228. PubMed ID: 3053126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of fluoroquinolones in the treatment of skin infections.
    Martin SJ; Zeigler DG
    Expert Opin Pharmacother; 2004 Feb; 5(2):237-46. PubMed ID: 14996621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of fluoroquinolones in skin and skin structure infections.
    Blondeau JM
    Am J Clin Dermatol; 2002; 3(1):37-46. PubMed ID: 11817967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gatifloxacin: a review of its use in the management of bacterial infections.
    Perry CM; Ormrod D; Hurst M; Onrust SV
    Drugs; 2002; 62(1):169-207. PubMed ID: 11790160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
    Lipsky BA; Miller B; Schwartz R; Henry DC; Nolan T; McCabe A; Magner DJ; Talbot GH
    Clin Ther; 1999 Apr; 21(4):675-90. PubMed ID: 10363733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial therapy in dermatology].
    Sunderkötter C; Herrmann M; Jappe U
    J Dtsch Dermatol Ges; 2006 Jan; 4(1):10-27. PubMed ID: 16503927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin and trovafloxacin: the next generation of fluoroquinolones?
    Ernst ME; Ernst EJ; Klepser ME
    Am J Health Syst Pharm; 1997 Nov; 54(22):2569-84. PubMed ID: 9397218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy with newer oral beta-lactam and quinolone agents for infections of the skin and skin structures: a review.
    Gentry LO
    Clin Infect Dis; 1992 Jan; 14(1):285-97. PubMed ID: 1571443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF; Goa KL
    Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.